Model Formulation Sample Clauses

Model Formulation. Hydrologic parameters will be derived from the site-scale and regional-scale models. Spatial discretization may be finer than regional-scale models for computational purposes. Hydraulic and thermal properties will be generalized within hydrostratigraphic layers. The model will use a single porosity and permeability within each model element. The model will not include any postulated repository affects and only ambient groundwater temperatures will be considered. The thermal model of the LHG will approximate to the current saturated zone regional interpretation. The thermal model will be steady state for both groundwater flow and thermal transport. The top of the model will be a prescribed hydraulic flux and temperature at the water table. The model will extend to the depth of the Paleozoic carbonate aquifer or deepest thermal log. The bottom of the model will be simulated as a prescribed hydraulic head and a spatially variable thermal flux. The upgradient and downgradient boundaries will be prescribed hydraulic fluxes or hydraulic heads based on the requirements for numerical stability. Both the hydraulic heads and groundwater temperatures will vary with depth. Hydraulic head at the water table surface and any hydraulic heads at depth will be the calibration parameters. The spatial thermal distribution between the upgradient and downgradient boundaries will be the evaluation parameters. Thermal rock properties will be extracted from the project database. Because there is less thermal data at distance from the potential repository location, generalized information will be used in the thermal model. The methodology of Rautman (1995) may be used to assign thermal conductivity unless data that are more explicit are available. DOCUMENT CHANGE NOTICE (DCN) page 4 of 5 DCN No. 1 to Document No. SIP-DRI-039, Revision 0, Effective Date: 15FEB05.
AutoNDA by SimpleDocs
Model Formulation. This section formulates the mathematical model for deciding about the surplus inventory at the beginning of each quality period. The supermarket pays the supplier for buying product i which equals 𝑐𝑖𝐷𝑖 and anticipates to sell them during the quality period j with the price 𝑠𝑖𝑖𝑖 and the quantity 𝑃′𝑖𝑖𝑖 which leads to a revenue 𝑠𝑖𝑖𝑖 𝑃′𝑖𝑖𝑖. So, the total revenue that the supermarket anticipates for the predefined evaluation period equals the following equation. 𝑇𝑅′ = ∑ ∑𝑛𝑖 𝑠 𝑃′ − ∑ 𝑐 𝐷 (1) 𝑖𝑖=1 𝑖 𝑖 Considering equation (1) for a specific product (product i), the equation can be revised as follows. 𝑇𝑅′ = ∑𝑛𝑖 𝑠 𝑃′ − 𝑐 𝐷
Model Formulation. Our model represents the population dynamics of two bacteria, Sphingomonas sp. TFEE and Burkholderia sp. MN1, in fenitrothion-treated soil (Fig. 2 and Table 2). The variables S0, S1, and S2 denote the concentrations of fenitrothion, 3M4N, and MHQ in the soil, respectively. The population densities of Sphingomonas sp. TFEE and Burkholderia sp. MN1 are denoted by x1 and x2, respectively. The repeated application of fenitrothion is represented by λ. Although bacterial degradation is considered to be a major factor determining the fate of fenitrothion, 3M4N, and j j i a +S MHQ, these compounds naturally decompose over time, as represented by −d0S0, d1S1, and d2S2, respectively. We do not consider any possibilities that metabolite 3M4N and MHQ are produced via natural decomposition of fenitrothion and 3M4N. We assume that the uptake rate of 3M4N and MHQ follows the conventional formulation known as Xxxxxxxxx-Xxxxxx kinetics, with a half-saturation constant aj and maximum uptake rate m of the form: f (S ) := mj Si , (i, j = 1, 2). Popula- j i tion growth of the bacteria is simply proportional to the uptake of substrates with constant conversion rates (i.e., yields) of η1 for Sphingomonas sp. TFEE and η2 for Burkholderia sp. MN1, respectively. Conventionally we can assume that interaction between enzyme and substrate follows the mass action law (Xxxxxx et al., 1998). Let E(t) denote the concentration of the fenitrothion-degrading enzyme synthesized by Sphingomonas sp. TFEE. We assume that E(t) is proportional to the population density of Sphingomonas sp. TFEE, that is, E(t) = kx1(t). Hence the concentration of enzyme–substrate complex is given by β'S0E := βS0x1. Here constant β = kβ' represents the rate of decomposition of enzyme–substrate complex into 3M4N and enzyme. Following the experimental observations, we assume that a portion of MHQ is excreted from Burkholderia sp. MN1 after the metabolism of 3M4N. Let γ denote the fraction of MHQ excreted by Burkholderia sp. MN1. By definition, γ must be assigned a value between 0 and 1. Hence the total excretion of MHQ is given by γf2(S1)x2/η2. The remaining (1 γ)f2(S1)x2/η2 is exploited for the population growth of Burkholderia sp. MN1. Loss of activity for individual bacterium can oc- cur via starvation, mutation, being prey to predation, or other factors. We simply assume that the loss rates of Sphingomonas sp. TFEE and Burkholderia sp. MN1 are given by µ1x1 and µ2x2, respectively. The model, including all of the ab...
Model Formulation 

Related to Model Formulation

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

  • Reformulation of Products As of the Effective Date, and continuing thereafter, Products that Xxxxx directly manufactures, imports, distributes, sells, or offers for sale in California shall either: (a) be Reformulated Products pursuant to § 2.2, below; or (b) be labeled with a clear and reasonable exposure warning pursuant to §§ 2.3 and 2.4, below. For purposes of this Settlement Agreement, a “Reformulated Product” is a Product that is in compliance with the standard set forth in

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time. (b) The Supplier shall not change any process, material, component, packaging or manufacturing location without the Purchaser’s express prior written approval.

  • Products Products available under this Contract are limited to Software, including Software as a Service, products and related products as specified in Appendix C, Pricing Index. Vendor may incorporate changes to their product offering; however, any changes must be within the scope of products awarded based on the posting described in Section 1.B above. Vendor may not add a manufacturer’s product line which was not included in the Vendor’s response to the solicitation described in Section 1.B above.

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

  • Labelling The distributor, on behalf of the selected vendor agrees that all supplies of articles should invariably contain the following information on its label and the carton. One information should not be overlapped by any other information needed to be furnished. The label should contain : a. Name of the item as approved b. CMS Cat. No. c. Manufacturing date/Import date for the imported items. d. Expiry Date. (where applicable) e. Name & address of Registered Office of Manufacturers and place of manufacture. f. Manufacturing License Number. (where applicable for Manufactures) g. Batch Number (where applicable) h. Month and Year of supply. i. The label & Carton must invariably marked “W B. GOVT SUPPLY : NOT FOR SALE”. j. All Surgical items quoted/supplied by the tenderer must conform to IS /BIS /CE/USFDA. Pacemker must conform to CE & US FDA norms. In case of Drugs items quoted /supplied by tenderer MUST CONFORM TO IP, BP, or USP norms and N.F.I. –III specification as noted against the item(s) in catalogue as applicable. k. The MRP and Trade Name will not be allowed to be printed in any pack. This will lead to cancellation of candidature straightaway. However, for excisable products, insertion of writing of Govt MRP is allowed as per provision laid down in the order of the Central Excise dept. However, for imported item(s), MRP and Trade name may be allowed in addition to Generic name.

  • ODUF Packing Specifications 6.3.1 A pack will contain a minimum of one message record or a maximum of 99,999 message records plus a pack header record and a pack trailer record. One transmission can contain a maximum of 99 packs and a minimum of one pack.

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • Product Specifications (a) Supplier shall manufacture all Products according to the Specifications in effect as of the date of this Agreement, with such changes or additions to the Specifications of the Products related thereto as shall be requested by Buyer in accordance with this Section or as otherwise agreed in writing by the Parties. All other Products shall be manufactured with such Specifications as the Parties shall agree in writing. (b) Buyer may request changed or additional Specifications for any Product by delivering written notice thereof to Supplier not less than one hundred twenty (120) days in advance of the first Firm Order for such Product to be supplied with such changed or additional Specifications. Notwithstanding the foregoing, if additional advance time would reasonably be required in order to implement the manufacturing processes for production of a Product with any changed or additional Specifications, and to commence manufacture and delivery thereof, Supplier shall so notify Buyer, and Supplier shall not be required to commence delivery of such Product until the passage of such additional time. (c) Supplier shall be required to accommodate any change of, or additions to, the Specifications for any Product, if and only if (i) in Supplier’s good faith judgment, such changed or additional Specifications would not require Supplier to violate good manufacturing practice, (ii) the representation and warranty of Buyer deemed made pursuant to Subsection (e) below is true and correct, and (iii) Buyer agrees to reimburse Supplier for the incremental costs and expenses incurred by Supplier in accommodating the changed or additional Specifications, including the costs of acquiring any new machinery and tooling. For the avoidance of doubt, such costs and expenses shall be payable by Buyer separately from the cost of Products at such time or times as Supplier shall request. (d) Supplier shall notify Buyer in writing within thirty (30) days of its receipt of any request for changed or additional Specifications (i) whether Supplier will honor such changed or additional Specifications, (ii) if Supplier declines to honor such changed or additional Specifications, the basis therefor and (iii) if applicable, the estimated costs and expenses that Buyer will be required to reimburse Supplier in respect of the requested changes or additions, as provided in Subsection (c) above. Buyer shall notify Supplier in writing within fifteen (15) days after receiving notice of any required reimbursement whether Buyer agrees to assume such reimbursement obligation. (e) By its request for any changed or additional Specifications for any Product, Buyer shall be deemed to represent and warrant to Supplier that the manufacture and sale of the Product incorporating Buyer’s changed or additional Specifications, as a result of such incorporation, will not and could not reasonably be expected to (i) violate or conflict with any contract, agreement, arrangement or understanding to which Buyer and/or any of its Affiliates is a party, including this Agreement and any other contract, agreement, arrangement or understanding with Supplier and/or its Affiliates, (ii) infringe on any trademark, service xxxx, copyright, patent, trade secret or other intellectual property rights of any Person, or (iii) violate any Applicable Law. Buyer shall indemnify and hold Supplier and its Affiliates harmless (including with respect to reasonable attorneys’ fees and disbursements) from any breach of this representation and warranty.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!